SCHEMBL208452

SCHEMBL208452

COC1CCC([C@@H](c2c(Cl)cc(-c3ccc(C(=O)O)cc3)cc2Cl)C2CCNC2=O)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 2/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
RXRA P19793 4/20 0.35
RXRB P28702 3/20 0.34
PDE5A O76074 1/20 0.34
PDE1A P54750 1/20 0.34
PDE1B Q01064 1/20 0.34
PDE7A Q13946 1/20 0.34
PDE1C Q14123 1/20 0.34
PDE3A Q14432 1/20 0.34
AKR1C2 P52895 1/20 0.34
AKR1C1 Q04828 1/20 0.34
PRKAB2 O43741 1/20 0.33
PRKAG1 P54619 1/20 0.33
PRKAA2 P54646 1/20 0.33
PRKAA1 Q13131 1/20 0.33
PRKAG3 Q9UGI9 1/20 0.33
PRKAG2 Q9UGJ0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL208949 0.91 RHEB (0.36) SLC6A2SLC6A4SLC6A3
SCHEMBL4060990 0.88 SRD5A2 (0.32) PDE4DPDE4APDE4BPDE4CRXRA
SCHEMBL208541 0.88 SRD5A2 (0.32) PDE4DPDE4APDE4BPDE4CRXRA
SCHEMBL209307 0.87 PDE4D (0.41) PDE4DPDE4APDE4BPDE4CRXRA
SCHEMBL209158 0.86 MEN1 (0.32) PDE4DPDE4APDE4BPDE4CRXRA
SCHEMBL208778 0.86 MEN1 (0.32) PDE4DPDE4APDE4BPDE4CRXRA
SCHEMBL4067647 0.85 POLB (0.37) PDE4DRXRARXRBPDE5APDE1A
SCHEMBL209419 0.85 POLB (0.37) PDE4DRXRARXRBPDE5APDE1A
SCHEMBL3946179 0.83 PDE5A (0.39) PDE4DRXRARXRBPDE5APDE1A
SCHEMBL4207175 0.83 PDE5A (0.39) PDE4DRXRARXRBPDE5APDE1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 PDE4D 1270/4885PDE4A 1263/4885PDE4B 1307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.